Jamba, Inc.:企業の戦略・SWOT・財務分析

◆英語タイトル:Jamba, Inc. - Strategy, SWOT and Corporate Finance Report
◆商品コード:SWOT20MY5256
◆発行会社(調査会社):MarketLine
◆発行日:2020年3月
◆ページ数:44
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Leisure and Arts
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥19,250見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥38,500見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥57,750見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Jamba, Inc. – Strategy, SWOT and Corporate Finance Report
Summary

Jamba, Inc. – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Jamba, Inc. (Jamba) is a holding company. The company owns, operates and franchises restaurants and juice stores through its subsidiary Jamba Juice Company. It primarily offers specialty beverages and food items including juices, fruit smoothies, oatmeal, juice blends, energy drinks, Artisan flatbreads, sandwiches, breakfast wraps, shots, freshly squeezed juices,
tasty bites, and a range of baked foods and snacks. Jamba markets and sells products through its owned and franchised Jamba Juice stores and Jamba Juice Express format. The company operates and franchises stores across the US, South Korea, the Philippines, the UAE, Taiwan, and Thailand. Jamba is headquartered at Emeryville, California, the US.

Scope

- Detailed information on Jamba, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Jamba, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Jamba, Inc. including a breakdown and examination of key business segments
- Intelligence on Jamba, Inc.’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Jamba, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to Buy

- Gain understanding of Jamba, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Jamba, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Jamba, Inc.’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot
Table of Contents
Jamba, Inc.: Company Overview
Jamba, Inc.: Overview and Key Facts
Jamba, Inc.: Overview
Jamba, Inc.: Key Facts
Jamba, Inc.: Key Employees
Jamba, Inc.: Key Employee Biographies
Jamba, Inc.: Major Products and Services
Jamba, Inc.: Company History
Jamba, Inc.: Management Statement
Jamba, Inc.: Locations and Subsidiaries
Jamba, Inc.: Key Competitors
Jamba, Inc.: Company Analysis
Jamba, Inc.: Business Description
Jamba, Inc.: SWOT Analysis
Jamba, Inc.: SWOT Overview
Jamba, Inc.: Strengths
Jamba, Inc.: Weaknesses
Jamba, Inc.: Opportunities
Jamba, Inc.: Threats
Jamba, Inc.: Corporate Financial Deals Activity
Jamba, Inc.: Financial Deals Overview
Jamba, Inc.: Top Deals 2016 – 2020YTD*
Jamba, Inc.: Advisors
Jamba, Inc.: Top Legal Advisors
Jamba, Inc.: Top Financial Advisors
Jamba, Inc.: Divestments
Jamba, Inc.: Private Equity and Ownership
Jamba, Inc.: Recent Developments
Jamba, Inc.: News and Events Summary
Jamba, Inc.: Business Expansion
Jamba, Inc.: Contracts
Jamba, Inc.: Corporate Governance
Jamba, Inc.: Financial Deals
Jamba, Inc.: Financial Performance
Jamba, Inc.: Regulatory and Legal Events
Jamba, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine

List of Tables
Table 1: Jamba, Inc.: Key Facts
Table 2: Jamba, Inc.: Key Employees
Table 3: Jamba, Inc.: Company History
Table 4: Jamba, Inc.: Locations and Subsidiaries
Table 5: Jamba, Inc.: Key Competitors
Table 6: Jamba, Inc.: Deal Activity by Deal Type - Volume (2016 - YTD*2020)
Table 7: Jamba, Inc.: Top Deals 2016 - 2020YTD*
Table 8: Jamba, Inc.: Legal Advisor Ranking by Value (US$m)
Table 9: Jamba, Inc.: Financial Advisor Ranking by Value (US$m)
Table 10: Jamba, Inc.: Divestments Volume and Value Trend (2016 - YTD*2020)
Table 11: Jamba, Inc.: Private Equity and Ownership Volume and Value Trend (2016 - YTD*2020)
Table 12: Jamba, Inc.: Private Equity and Ownership Volume by Deal Type (2016 - YTD*2020)
Table 13: Jamba, Inc.: News and Events Summary
Table 14: Jamba, Inc.: Business Expansion
Table 15: Jamba, Inc.: Contracts
Table 16: Jamba, Inc.: Corporate Governance
Table 17: Jamba, Inc.: Financial Deals
Table 18: Jamba, Inc.: Financial Performance
Table 19: Jamba, Inc.: Regulatory and Legal Events
Table 20: Jamba, Inc.: Strategy and Operations

★海外企業調査レポート[Jamba, Inc.:企業の戦略・SWOT・財務分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abbott Diagnostics:企業の製品パイプライン分析2018
    Summary Abbott Diagnostics, a subsidiary of Abbott Laboratories, is a manufacturer of in vitro diagnostic systems and tests. The company offers core laboratory products, molecular point of care products, transfusion medicine, professional services and diagnostics portfolio. Its products include labo …
  • Raytheon Technologies Corp (RTX):企業の財務・戦略的SWOT分析
    Raytheon Technologies Corp (RTX) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and wea …
  • John Wood Group Plc (WG.):石油・ガス:M&Aディール及び事業提携情報
    Summary John Wood Group Plc (Wood) is a provider of project, engineering and technical services. The company offers comprehensive solutions that improve the performance of customers' industrial assets across the asset life cycle. Its services span from concept to decommissioning and include asset so …
  • TriLink BioTechnologies Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary TriLink BioTechnologies Inc (TriLink), a subsidiary of Maravai Life Sciences Inc, is a manufacturer of modified nucleic acid products. The company’s products include oligonucleotides, nucleotides, custom chemistry, DNA synthesis reagents, cleanamp PCR products, modified nucleoside triphospha …
  • Bounty Oil & Gas NL (BUY):企業の財務・戦略的SWOT分析
    Bounty Oil & Gas NL (BUY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Ramsay Health Care Ltd (RHC):企業の財務・戦略的SWOT分析
    Ramsay Health Care Ltd (RHC) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Orchid Pharma Ltd (ORCHIDPHAR):企業の財務・戦略的SWOT分析
    Summary Orchid Pharma Ltd (Orchid), formerly Orchid Chemicals & Pharmaceuticals Ltd is a pharmaceutical company that develops and manufactures pharmaceutical solutions such as formulations and API products. The company offers formulations such as cardiovascular products, neuropsychiatry products, an …
  • University College London Hospitals NHS Foundation Trust:企業の戦略的SWOT分析
    University College London Hospitals NHS Foundation Trust - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key …
  • Sunway REIT Management Sdn Bhd:企業の戦略・SWOT・財務情報
    Sunway REIT Management Sdn Bhd - Strategy, SWOT and Corporate Finance Report Summary Sunway REIT Management Sdn Bhd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product a …
  • iTeos Therapeutics SA:製薬・医療:M&Aディール及び事業提携情報
    Summary iTeos Therapeutics SA (iTeos) is a biotechnology company that develops novel cancer immunotherapies. The company’s pipeline products include small molecule immunomodulators targeting IDO1, A2A, immune check points, STING agonist, and antibodies directed to TIGIT and Galectin 3. It also devel …
  • Taiheiyo Cement Corporation
    Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report Summary Taiheiyo Cement Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • JACCS Co., Ltd.:企業の戦略・SWOT・財務情報
    JACCS Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary JACCS Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Ergon Inc:企業の戦略的SWOT分析
    Ergon Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Th …
  • Insight Genetics Inc:医療機器:M&Aディール及び事業提携情報
    Summary Insight Genetics Inc (Insight Genetics) is a molecular diagnostic company which discovers, develops and commercializes companion diagnostics. The company offers assays for triple negative breast cancer; and a suite of molecular tests including anaplastic lymphoma kinase (ALK), ROS1 and RET f …
  • Golden Gate Capital:企業の戦略的SWOT分析
    Golden Gate Capital - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • China Petroleum & Chemical Corp:企業の戦略・SWOT・財務情報
    China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report Summary China Petroleum & Chemical Corp - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Icagen Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Icagen Inc (Icagen) (formerly known as XRpro Sciences, Inc.) is a biopharmaceutical company which develops drug candidates to unmet medical needs. The company discovers drug for clinical stage across multiple therapeutics and ion class channel classes. The company provides technologies inclu …
  • Vectren Corp (VVC):石油・ガス:M&Aディール及び事業提携情報
    Summary Vectren Corp (Vectren) is an energy holding company, which carries out the distribution and transmission of natural gas and electricity. Under its wholly owned subsidiary, Vectren Utility Holdings, Inc., the company operates three utilities; Vectren Energy Delivery of Indiana - North (Vectre …
  • D.R. Horton Inc:戦略・SWOT・企業財務分析
    D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report Summary D.R. Horton Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Audentes Therapeutics Inc (BOLD):企業の財務・戦略的SWOT分析
    Summary Audentes Therapeutics Inc (Audentes) is a biotechnology company that focuses on the development and commercialization of gene therapy products for rare diseases. The company’s pipeline products include AT132, intended for the treatment of X-linked myotubular myopathy; AT982, for the treatmen …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆